A Randomized, Double-Blind, Active-Controlled Trial to Evaluate Intravenous and Oral PRT060128, A Selective and Revirsible P2Y12-Receptor Inhibitor vs Clopidogrel, as a Novel Antiplatelet Therapy in Patients Undergoing

  • Ziada, Khaled (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/098/31/11